G+FLAS Life Sciences
PrivateLast Round
Series C
Sep 3, 2019
Total Funding Raised
$28M
Company Overview
G+FLAS Life Sciences is a biotechnology company that develops new drugs, biopharmaceuticals, and novel seeds based on CRISPR gene editing technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
G+FLAS Life Sciences Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
G+FLAS Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 3, 2019 | ||||
| Series B | Jul 19, 2018 | ||||
| Series A | Mar 1, 2017 | ||||
| Seed | Mar 1, 2016 |
G+FLAS Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Smilegate Investment | Series C |
| The Wells Investment | Series A |
| ActnerLab | Seed |
| Alpen Route | Series C |
| DS Asset Management | Series B |
| Timefolio Asset Management | Series B |
| Daesung Private Equity | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors grew 169% MoM, reaching 6.2K.
- May 2, 2025
Monthly visitors grew 36% MoM, reaching 1.5K.
G+FLAS Life Sciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about G+FLAS Life Sciences's valuation, stock price, and market status.